N
SONM icon

Nuveen’s DNA X Inc SONM Stock Holding History

Nuveen’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-41
Closed -$268K – 3257
2019
Q4 		$268K Hold
41
– – ﹤0.01% 3036
2019
Q3 		$217K Buy
41
+28
+215% +$430K ﹤0.01% 3110
2019
Q2 		$309K Buy
+13
New +$330K ﹤0.01% 3115

Other funds holding SONM

NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Nuveen's SONM Position: Q1 2020 in Review

Nuveen sold out of DNA X Inc (SONM) in Q1 2020, closing a stake of 41 shares — an estimated $268K sold.

Nuveen first reported a position in SONM in Q2 2019 and held it in 3 quarters. The position peaked at $309K in Q2 2019. 37 funds tracked by Wall St. Rank hold SONM as of Q1 2020.

  • Nuveen reported no remaining DNA X Inc position as of Q1 2020 after selling out during the quarter.
  • Nuveen sold 41 DNA X Inc shares in Q1 2020, an estimated $268K.
  • Nuveen first reported a position in DNA X Inc in Q2 2019 and held it in 3 quarters.
  • Nuveen's DNA X Inc position peaked at $309K in Q2 2019.
  • 37 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2020.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.